Menu

News & Insights

  • Clear

CVS Settles with Alaska AG for $10 Million over Opioid Allegations

Alaska AG Treg Taylor has reached a settlement with CVS Pharmacy, Inc. to resolve allegations that the company violated Alaska’s Unfair Trade Practices and Consumer Protection Act by allegedly dispensing opioid-containing prescription drugs without first making sufficient inquiries into the legitimacy of a prescription.

Read More

Kentucky AG Brings Latest Opioid Epidemic Lawsuit

Kentucky AG Russell Coleman filed a lawsuit against the Kroger Company and affiliated entities alleging that it contributed to the opioid epidemic in the state in its role as a drug distributor and operator of retail pharmacies. According to the complaint, Kroger allegedly distributed and dispensed opioids in the state between 2006 and 2019, while…

Read More

AGs Net $500 Million in Opioid Epidemic Settlements

Multistate groups of AGs reached two settlements related to claims involving the U.S. opioid epidemic. Publicis Health, LLC settled with a coalition consisting of all AGs from every state, territory, and the District of Columbia to resolve allegations that the advertising agency designed and deployed unfair and deceptive marketing schemes in order to help Purdue…

Read More

Texas AG Paxton Indicates Disapproval for Marijuana Amnesty Cities

Texas AG Ken Paxton filed lawsuits against the Texas cities of Austin, Denton, Elgin, Killeen, and San Marcos alleging that their adoption of so-called “marijuana amnesty” policies violates Texas state law. In the complaints, AG Paxton alleges that the cities’ adoption of ordinances designed to eliminate marijuana enforcement within their boundaries violates provisions of the…

Read More

AGs Say it’s High Time for the Federal Government to Reschedule Cannabis

A coalition of 12 AGs wrote a letter to the Drug Enforcement Administration (DEA) in support of federal efforts to evaluate and reschedule cannabis from Schedule I to Schedule III under the federal Controlled Substances Act. A Schedule I classification is reserved for substances with no medical value and those that are considered highly addictive,…

Read More